Lv1
54 积分 2021-11-09 加入
Lentiviral particle-mediated generation of in-vivo CAR-T cells for treating refractory B-cell lymphoma
30天前
已完结
Triple knockdown of CD11a , CD49d , and PSGL1 in T cells reduces CAR-T cell toxicity but preserves activity against solid tumors in mice
1个月前
已完结
Roads and detours for CAR T cell therapy in autoimmune diseases
2个月前
已完结
Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus
2个月前
已完结
In vivo chimeric antigen receptor (CAR)-T cell therapy
2个月前
已完结
Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study
3个月前
已完结
In vivo chimeric antigen receptor (CAR)-T cell therapy
3个月前
已完结
Easy and accurate protein structure prediction using ColabFold
3个月前
已完结
Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study
3个月前
已完结
Stable expression of large transgenes via the knock-in of an integrase-deficient lentivirus
3个月前
已完结
皖公网安备34019202002308
